An early repolarization (ER) pattern in the ECG, distinguished by J-point elevation, slurring of the terminal part of the QRS and ST-segment elevation has long been recognized and considered to be a benign electrocardiographic manifestation. Experimental studies conducted over a decade ago suggested that some cases of ER may be associated with malignant arrhythmias. Validation of this hypothesis was provided by recent studies demonstrating that an ER pattern in the inferior or inferolateral leads is associated with increased risk for life-threatening arrhythmias, termed ER syndrome (ERS). Because accentuated J waves characterize both Brugada syndrome (BS) and ERS, these syndromes have been grouped under the term "J wave syndromes". ERS and BS share similar ECG characteristics, clinical outcomes and risk factors, as well as a common arrhythmic platform related to amplification of Itomediated J waves. Although BS and ERS differ with respect to the magnitude and lead location of abnormal J wave manifestation, they can be considered to represent a continuous spectrum of phenotypic expression. Although most subjects exhibiting an ER pattern are at minimal to no risk, mounting evidence suggests that careful attention should be paid to subjects with "high risk" ER. The challenge ahead is to be able to identify those at risk for sudden cardiac death. Here I review the clinical and genetic aspects as well as the cellular and molecular mechanisms underlying the J wave syndromes. (Circ J 2012; 76: 1054 - 1065 
The J wave or elevated J point has been depicted in the ECG of animals and humans since the early 1930 s. It was first described by Tomaszewski in 1938 in an accidentally frozen human. 1 The term was also known as an Osborn wave after being highlighted by Osborn in hypothermic dogs. 2 In humans, the appearance of a prominent J wave in the ECG is pathognomonic of hypothermia, 3-5 hypercalcemia 6, 7 and more recently as a marker for a substrate capable of generating life-threatening ventricular arrhythmias. 8 A distinct J wave has been described in subjects completely recovered from hypothermia 9,10 or those predisposed to idiopathic ventricular fibrillation, but is otherwise rarely observed in humans under normal conditions. In animals, a distinct J wave is commonly observed in the ECG of some species, such as baboons and dogs, under baseline conditions and is greatly accentuated under hypothermic conditions. 11- 13 An elevated J point, on the other hand, is commonly encountered in humans and some animal species under normal conditions.
To the best of our knowledge, the term "early repolarization (ER)" was first coined by Grant et al 14 to describe ST-segment deviations and associated T-wave changes and thought to result from premature repolarization. The ER pattern in the ECG has in recent years been shown to be associated with life-threatening arrhythmias, describing an entity now termed ER syndrome (ERS). Although Brugada syndrome (BS) and ERS differ with respect to the magnitude and lead location of the abnormal J wave manifestation, they are thought to represent a continuous spectrum of phenotypic expression, termed "J wave syndromes". 8 An ER pattern in the ECG, consisting of a distinct J wave or J point elevation, a notch or slur of the terminal part of the QRS and an ST-segment elevation is generally found in healthy young males and has traditionally been viewed as benign. 15, 16 The observation in 2000 that an ER pattern in the canine coronary-perfused wedge preparation can readily convert to 1 in which phase 2 reentry gives rise to polymorphic ventricular tachycardia/ventricular fibrillation (VT/VF), prompted the suggestion that ER may in some cases predispose to malignant arrhythmias in the clinic. 8,17, 18 A number of case reports and experimental studies have suggested a critical role for the J wave in the pathogenesis of idiopathic VF (IVF). [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] A definitive association between ER and IVF was presented in the form of 2 studies published in 2008, 29,30 followed by another study from Viskin et al 31 that same year and large population association studies in 2009 and 2010. [32] [33] [34] [35] [36] In a case-control study of 206 patients surviving an episode of IVF and 412 matched controls, Haissaguerre et al demon-
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strated that 31% of the IVF group, compared with 5% of the controls, displayed an ER pattern consisting of a J-point elevation (>0.1 mV), slurring of the terminal part of the QRS and ST-segment elevation in the inferior and/or lateral ECG leads. 32 In the same issue of the New England Journal of Medicine, Nam et al reported that 60% of their IVF patients exhibited an ER pattern. 30 In 4 of their patients who presented with electrical storm, continuous ECG monitoring revealed a unique electrocardiographic signature consisting of an ER pattern in the inferolateral leads at baseline and dramatic transient accentuation of the J waves in the inferolateral leads and the development of a marked J waves or ST-segment elevation in the right precordial leads, just before the development of VT/ VF. The electrical storms were precipitated by a relatively short-coupled premature ventricular beat and the ST-segment elevation was not apparent in the right precordial leads at any other time. 30 The accentuated J waves and VF could be suppressed with quinidine and isoproterenol or with pacing at increasingly rapid rates. Interestingly, the electrocardiographic and arrhythmic abnormalities could not be provoked with intravenous flecainide in these type 3 ERS patients, as they are in cases of BS.
A number of case-control studies followed confirming the association between ER and IVF. 31,37-41 Interestingly, a recent case-control study examined the prognostic significance of ER among chronic coronary disease patients with ICD. 42 The prev-alence of inferior ER was significantly greater among patients who had appropriate ICD therapy for ventricular arrhythmias than in patients who were arrhythmia-free (28% vs. 8%, P=0.011), irrespective of their ejection fraction. The authors noted that ER prevalence was much greater among young males compared with females and that the higher prevalence in males declines rapidly with age, suggesting a potential influence of testosterone as a modifier of J wave or ER manifestation. This strong male predominance is observed with all of the J wave syndromes, 8 including BS. 43 Both clinical and experimental studies have provided evidence in support of the notion that testosterone plays an important role in ventricular repolarization. Ezaki et al 44 recently demonstrated that ST-segment elevation is relatively small and similar in males and females before puberty. After puberty, ST-segment elevation in males, but not females, increased dramatically, more so in the right precordial leads and decreased gradually with advancing age. The effect of androgen-deprivation therapy on the ST segment was also subsequently evaluated in 21 prostate cancer patients. Androgen-deprivation therapy significantly decreased ST-segment elevation. These results suggest that testosterone modulates the early phase of ventricular repolarization and thus ST-segment elevation.
The prognosis of inferior or inferolateral ER was also evaluated in several general population studies. 32,33,35,36,41, 45 In a with a mean follow-up of 30±11 years, the prevalence of inferolateral ER at entry was 5.8%. Inferior ER was associated with increased risk of cardiac mortality (RR 1.28, P=0.03), and inferior ER patterns with J-point elevation greater than 0.2 mV were associated with cardiac mortality (RR 2.98, P<0.001) and sudden arrhythmic death (RR 2.92, P=0.01). Interestingly, QTc duration >440 ms in males and 460 ms in females was associated with a smaller magnitude of increased risk for cardiac mortality (RR 1.20, P=0.03). 32 Sinner et al then reported a population-based study examining ER prevalence and prognosis in a German population of 1,945 subjects from the KORA/MONICA cohort. 33 Inferolateral ER was observed in 13.1% of the cohort, whereas inferior ER prevalence was 7.6%, both higher than those observed in the Finnish study. The risk of death from cardiac causes was greater in relatively young males with inferior ER. The presence of an ER pattern was associated with a 2-to 4-fold increased risk of cardiac mortality in individuals aged between 35 and 54 years.
Tikkanen et al then reported a further analysis of the Finnish population in which they subgrouped the inferior ER patterns into notched or slurred J wave patterns and into ascending or horizontal/descending ST segments following the J wave (Figure 1 ). 35 The risk for arrhythmic death did not differ between notched and slurred J wave ER patterns, but the authors reported a higher risk in subjects with horizontal or descending ST segments in the inferior leads (RR 1.62, 95% confidence interval [CI] 1.19-2.21) when compared with subjects with rapidly ascending ST segments (RR 1.01, P=NS). Rapidly ascending ST segments after the J wave was the most prevalent pattern observed in athletes. A horizontal/ascending ST segment combined with a 2-mm J-point elevation was associated with a still higher risk for arrhythmic death (RR 3.37, 95% CI 1.75-6.51). Rosso et al reported similar results, showing that a horizontal/descending ST segment following the J point is associated with a higher level of risk for VT/VF. 45 The Figure 2 . Relationship between the spike and dome morphology of the epicardial (Epi) action potential (AP) and the appearance of the J wave. ECG2 is a lead V5 ECG recorded in vivo from a dog. ECG1 is a transmural ECG recorded across the arterially-perfused left ventricular wedge isolated from the heart of the same dog. Both display a prominent J wave at the R-ST junction (arrows). The 2 upper traces are transmembrane APs simultaneously recorded from the Epi and M regions using floating microelectrodes. The preparation was paced at a basic cycle length of 4,000 ms. The sinus cycle length at the time ECG2 was recorded was 500 ms. The ECG J wave is temporally coincident with the notch of the Epi AP. Although the M cell AP also exhibits a prominent notch, it occurs too early to exert an important influence on the manifestation of the J wave. (Modified from Yan and Antzelevitch, 20 with permission.) J Wave Syndromes presence of J waves was associated with a history of idiopathic VF with an odds ratio (OR) of 4.0, but having both J wave and horizontal ST segment yielded an OR of 13.8 for idiopathic VF. Thus, the Tel-Aviv group reported that the combination of J wave with horizontal/descending ST segment greatly improves the ability to distinguish patients with idiopathic VF from controls. 45 Another population-based study of atomic bomb survivors in the Nagasaki region of Japan 41 reported that in subjects followed over a period of 46 years a stable ER pattern was found in 650 subjects, resulting in a prevalence of 29.3%. The ER pattern was defined as ≥0.1-mV elevation of the J point or ST segment, with notching or slurring in at least 2 inferior and/or lateral leads. An ER pattern was associated with an elevated risk of unexpected death, but a decreased risk of cardiac and all-cause death.
A classification scheme for ER based on the data available in the literature was suggested in 2010 ( Table 1) . 8 An ER pattern manifesting exclusively in the lateral precordial leads was designated as type 1; this form is prevalent among healthy male athletes and is thought to be associated with a relatively low level of risk for arrhythmic events. The ER pattern in the inferior or inferolateral leads was designated as type 2; this form is thought to be associated with a moderate level of risk. Finally, an ER pattern appearing globally in the inferior, lateral and right precordial leads was labeled type 3; this form is associated with the highest level of risk and in some cases has been associated with electrical storms. 8 It is noteworthy, that type 3 ER may be very similar to that of type 2, exhibiting inferolateral ER, except for brief periods just before the development of VT/VF when pronounced J waves are also observed in the right precordial leads (see Nam et al 46 for an example). BS represents a 4 th variant in which ER is limited to the right precordial leads.
Cellular Basis for the Electrocardiographic J Waves and Associated Arrhythmogenesis
A transmural voltage gradient caused by differences in the magnitude of the action potential notch (APN) has long been recognized as the basis for inscription of the electrocardiographic J wave. 47, 48 The ventricular epicardial (Epi) AP, particularly in the right ventricle, displays a prominent transient outward current (Ito)-mediated notch or spike and dome morphology. The presence of a prominent Ito-mediated APN in ventricular epicardium but not endocardium leads to the development of a transmural voltage gradient that manifests as a J wave or J-point elevation on the ECG. Direct evidence in support of this hypothesis was first obtained in the arteriallyperfused canine ventricular wedge preparation, 20 as illustrated in Augmentation of the net repolarizing current, whether secondary to a decrease of inward current or an increase of outward current, accentuates the notch, leading to augmentation of the J wave or the appearance of ST-segment elevation. A further increase in net repolarizing current can result in partial or complete loss of the AP dome (APD), leading to a transmural voltage gradient that manifests as an accentuated J wave or an ST-segment elevation. 18,49,50 In regions of the myocardium exhibiting a prominent Ito, such as the right ventricular epicardium, marked accentuation of the APN and a coved-type STsegment elevation are diagnostic of BS (Figure 5B) . Additional outward shift of the net current active during the early phase of the AP can lead to loss of the APD, thus creating a dispersion of repolarization between epicardium and endocardium, as well as within epicardium, between the region where the dome is lost and the regions in which it is maintained (Figure 5C) . Sodium-channel blockers such as procainamide, pilsicainide, propafenone, flecainide and disopyramide cause a further outward shift of current flowing during the early phases of the AP and are therefore effective in inducing or unmasking Loss of the APD is usually heterogeneous, resulting in marked abbreviation of the AP at some sites but not at others. The dome can then propagate from regions in which it is maintained to regions where it is lost, giving rise to a very closely-coupled extrasystole via phase 2 reentry (Figure 5D ). 57 The phase 2 reentrant beat is capable of initiating polymorphic VT or VF (Figures 5E,F) .
Although most studies point to the pathophysiology of BS as being repolarization abnormalities, secondary to accentuation of the notch in the early phases of the AP, recent data suggest the possibility that delayed depolarization in the right ventricular outflow tract may provide the principal substrate of the ST-segment elevation or J waves associated with BS. 58, 59 The repolarization vs. depolarization hypotheses controversy has been documented as a published debate. 60 The net outward shift of current may extend beyond the APN and thus lead to depression of the dome in addition to accentuating the J wave. Activation of the ATP-sensitive potassium current (IK-ATP) or depression of the inward calciumchannel current (ICa) can effect such a change (Figures 6A,B) . This is more likely to manifest in the ECG as an ER pattern consisting of a J-point elevation, slurring of the terminal part of the QRS and mild ST-segment elevation. The ER pattern facilitates loss of the dome secondary to agents or conditions that produce a further outward shift of net current, leading to the development of ST-segment elevation, phase 2 reentry and VT/VF (Figure 6C) . Inhibition of Ito shifts net current in the inward direction, thus normalizing the ST segment and suppressing the J wave and arrhythmic manifestation.
Clinical Manifestations of J Wave Syndromes
In both BS and ERS, the manifestation of the J wave or ER is dynamic, 27,61,62 with the most prominent ECG changes appearing just before the onset of VT/VF. 20-27,46,61, 62 Other ECG characteristics of ERS also closely match those of BS, including the presence of accentuated J waves, ST-segment elevation, pause and bradycardia-dependence, and short-coupled extrasystole-induced polymorphic VT/VF. Suppression of the ECG features by isoproterenol or pacing in ER patients further supports the notion that they share common underlying electrophysiologic abnormalities with BS patients. 46 However, salient diagnostic features of BS, such as provocation by sodium-channel blockers or positive signal-averaged ECG, are rarely observed in ERS patients. 30, 46 An exception to this rule appears to apply to ERS associated with SCN5A mutations. 63 Kawata et al recently showed that sodium-channel blockers attenuate ER in patients with ERS as well, apparently because of slowing of transmural conduction so that the J point shifts to a lower position on the terminal part of the QRS. 64
Genetics of J Wave Syndromes
BS has been associated with mutations in 12 different genes ( Table 2) . Greater than 300 mutations in SCN5A (Nav1.5, BS1) have been reported in 11-28% of BS probands. 65-67 Mutations in CACNA1C (Cav1.2, BS3), CACNB2b (Cavβ2b, BS4) and CACNA2D1 (Cavα2δ, BS9) are found in approximately 13% of probands. 68, 69 Mutations in glycerol-3-phophate dehydrogenase 1-like enzyme gene (GPD1L, BS2), SCN1B (β1subunit of Na channel, BS5), KCNE3 (MiRP2; BS6), SCN3B (β3-subunit of Na channel, BS7), KCNJ8 (BS8) and KCND3 (BS10) are more rare. 70-75 Mutations in these genes lead to loss-of-function in INa and ICa, as well as a gain-of-function in Ito or IK-ATP. MOG1 was recently described as a new partner of NaV1.5, playing a role in its regulation, expression and trafficking. A missense mutation in MOG1 was also associated with BS (BS11). 76 Mutations in KCNH2 and KCNE5, although not causative, have been identified as capable of modulating the substrate for the development of BS ( Table 2) . 77, 78 Lossof-function mutations in HCN4, causing a reduction in the pacemaker current, If, have the potential to unmask BS by reducing heart. 79 The genetic basis for ERS is slowly coming into better focus. The familial nature of ER patterns has been demonstrated in a number of studies. 34,80,81 In a study conducted by the Framingham Heart Study, siblings of ER subjects were twice as likely to have ER than non-ER subjects (OR 2.22, P<0.05). In another study of over 500 British families, ER was more than twice as likely to occur in children (OR 2.54, P=0.005) if one of the parents had an ER ECG pattern. 34, 80 ERS has been associated with mutations in 6 genes ( Table 3) . Consistent with the finding that IK-ATP activation can generate an ER pattern in canine ventricular wedge preparations, a rare variant in KCNJ8, responsible for the pore-forming subunit of the IK-ATP channel, has recently been reported in a patients with ERS as well as in those with BS. 73,82, 83 Recent studies from my group have also identified loss-of-function mutations in the α1 and β2 and α2δ subunits of the cardiac L-type calcium channel (CACNA1C, CACNB2 and CACNA2D1) in patients with ERS. 69 The most recent addition to the genes associated with ERS is SCN5A, which encodes the α subunit of the cardiac sodium channel. Watanabe et al found loss-offunction mutations in SCN5A in patients with idiopathic VT associated with ER. 63 Interestingly, it appears that SCN5A mutations are associated with a type 3 ERS in which a J point or ST-segment elevation is present in the right precordial leads as well as in the inferior and lateral leads under baseline conditions or following a sodium block challenge. 63 A working hypothesis is that an outward shift in repolariz- ERS, early repolarization syndrome. ANTZELEVITCH C ing current because of a decrease in the sodium-or calciumchannel currents or an increase in Ito, IK-ATP, IK-ACh, or other outward currents gives rise to the J wave syndromes (Figure 7) . The particular phenotype depends on the part of the heart that is principally affected and the ion channels involved. The J wave syndromes can be viewed as a spectrum of disorders that involve accentuation of the epicardial APN in different regions of heart, leading to the development of prominent J waves that predispose to the development of VT/VF. 8 In patients with BS, the appearance of prominent J waves is limited to the leads facing the right ventricular outflow tract where Ito is most prominent. The more prominent Ito in right ventricular epicardium provides for a greater outward shift in the balance of current, which promotes the appearance of the J wave in this region of the ventricular myocardium. In the case of ERS, the appearance of prominent J waves may be limited to other regions of the ventricular myocardium because of the presence of heterogeneities in the distribution of other currents such as IK-ATP.
Risk Stratification
As in most cases of BS, bradycardia accentuates ST-segment elevation, and tachycardia tends to normalize the ST segment in ERS. VF often occurs near midnight or in the early morning hours when heart rate is slower and parasympathetic tone is augmented. 23, 84 In BS, the manifestation of spontaneous ST-segment elevation has been associated with a higher risk for development of arrhythmic events. Risk stratification of asymptomatic patients remains a challenge. Indeed, the most debated issue is risk stratification of asymptomatic BS patients. Brugada et al 85, 86 reported that the risk for developing VT/VF is much greater in patients who are inducible during an electrophysiological study (EPS), whether or not a type 1 ST-segment elevation is spontaneously present and whether or not they are symptomatic. In asymptomatic spontaneous type 1 ECG patients, multivariate analysis showed that the only predictor of arrhythmic events is inducibility during an EPS.
In sharp contrast, other studies have failed to find an association between inducibility and cardiac arrhythmic events. [87] [88] [89] [90] [91] [92] [93] The incidence of VT/VF events during follow-up was too low (annual event rate, 0.8-1% 87,88 ) to demonstrate value for risk stratification based on EPS inducibility. Of note, the last consensus conference published in 2005 94 recommended that asymptomatic patients displaying a type 1 ST-segment elevation (either spontaneously or after sodium-channel blockade) undergo an EPS if a family history of sudden cardiac death (SCD) is suspected to be the result of BS. An EPS was also considered justified with a negative family history but a spontaneous type 1 ST-segment elevation. If inducible for ventricular arrhythmia, implantation of an ICD was recommended as either a Class IIa or IIb indication, meaning that conflicting evidence exists concerning usefulness and that the weight of evidence is either in favor of usefulness (Class IIa) or usefulness is not well established (Class IIb). The report also recommended that asymptomatic patients with no family history but who develop a type 1 ST-segment elevation only after sodiumchannel blockade should be closely followed up. The large number of studies conducted since the appearance of the last consensus statements that have failed to demonstrate an association between inducibility and risk calls into question the value or need for EPS in asymptomatic BS patients. The reason for the large disparity between the results of the Brugada brothers and those from other centers is not clearly evident.
A recent study by Makimoto et al reported that the number of extrastimuli that induces VT/VF serves as a prognostic indicator of risk in BS patients with type 1 ST-segment elevation. They reported that single or double extrastimuli were adequate for programmed electrical stimulation in patients with BS. 95 Asymptomatic BS patients with type I ST-segment elevation are also at increased risk compared with those manifesting a saddleback or type II ST-segment elevation. Some ECG patterns are associated with higher risk of symptoms or life-threatening events in BS, including higher J-point elevations, QRS duration >100 ms, and a prominent r' in lead aVR. 96 Athletes do not appear to have a higher prevalence of Brugada ECG patterns, despite the fact that many athletes display an ER pattern. 97 In the case of ERS, it is clear that the vast majority of individuals with ER are at no or minimal risk for arrhythmic events and sudden cardiac arrest. The great challenge for the future is to develop better risk stratification strategies and effective treatments for the J wave syndromes. Incidental discovery of a J wave on routine screening should not be interpreted as a marker of "high risk" for SCD because the odds for this leading to a fatal outcome are relatively low. 40 However, mounting evidence suggests that careful attention should be paid to subjects with "high risk" ER. Who is at high risk?
Although we are still on a very steep learning curve, available data suggest a number of guidelines for risk stratification ( Table 4 ). As with other inherited cardiac arrhythmia syndromes, the association of ER with syncope, aborted SCD or a family history of SCD is a marker of risk. Appearance of prominent and distinct J waves, 98 transient augmentation of J waves or J-point elevation >0.2 mV in the inferior or inferolateral ECG leads should raise a red flag. 28,32,34 Association of ER with horizontal or descending ST segment or short QT intervals. 35, 36, 99 Finally, the appearance of very short-coupled extrasystoles are thought to be a marker of risk because they likely reflect phase 2 reentry, the presumed trigger for the development of polymorphic VT in the J wave syndromes. 8 1. Association of ER pattern with SCD, unexplained syncope, or unexplained family history of SCD.
2. J point or ST-segment elevation ≥0.2 mV in inferior and inferolateral or global leads.
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Differentiating J Waves Caused by Conduction vs. Repolarization
Perturbations in the terminal phase of the AP, which are generally referred to as J waves, can arise from either repolarization or depolarization abnormalities. When caused by the latter, the apparent J wave is expected to appear as a notch interrupting the terminal part of the QRS, with little or no STsegment elevation. As previously discussed, a straightforward way of distinguishing between the 2 mechanisms is to examine the effect of rate or atrial premature responses. When caused by delayed conduction, the notched appearance should become accentuated with acceleration of rate or prematurity, and when caused by repolarization problems, the amplitude of the J wave should diminish. These different responses are because delayed conduction almost invariably becomes more accentuated at faster rates or with prematurity, whereas the Ito -mediated APN diminishes because of insufficient time for the Ito to reactivate.
